The study offered RNA analysis for CDK4 and CDKN2A in the archival tumor material with the assumption that if a biomarker expression fitting with the inclusion criteria was found, then the screening at baseline would render a highly probable similar RNA expression. Here, CDK4 is linked to neoplasm.